Sg3 Management, LLC Gossamer Bio, Inc. Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $7,200 - $21,900	-7,500 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$7.21 - $14.88 $54,075 - $111,600	7,500 New	7,500 $89,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $97,878 - $163,458	-16,395 Reduced 68.61%	7,500 $63,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $201,673 - $298,448	23,895 New	23,895 $207,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $14,500 - $26,460	-2,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $16,000 - $19,500	2,000 New	2,000 $16,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $49,800 - $81,540	-6,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $67,800 - $88,500	6,000 New	6,000 $74,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.